InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Jerman Michael Allen. Officer active across 1 company, notably Inhibitor Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Activity tracked since 1 April 2024. The latest transaction was disclosed on 1 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations